Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

This study has been completed.

Study NCT00082121 Information provided by Avant Immunotherapeutics

First Received: April 29, 2004 Last Updated: July 19, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2005
Estimated Primary Completion Date:	No date given